Bimekizumab exhibited superior drug survival rates among patients with psoriasis who have previously stopped responding to at least one biologic, according to a real-world study. The ever-shifting ...
Nasha is a Managing Editor for CNET, overseeing our sleep and wellness verticals. She is a nutrition, mental health, fitness and sleep science enthusiast. Her passion for mindful and holistic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback